Professional Activities, Patents, and Honors
*U.S. Patent 7,157,079: Granted Jan 2, 2007. Combined tumor suppressor gene therapy and chemotherapy for cancer.
*U.S. Patent 6,333,333: Granted Dec 25, 2001. Combined farnesyl transferase inhibitor and chemotherapy for cancer
*U.S. Patent 6,096,757: Granted Aug 1, 2000. Combined farnesyl transferase inhibitor and chemotherapy for cancer
*Lilly Exenatide Project Team Recognition Award: 2005
*Amylin/Lilly Exenatide Alliance Certificate of Recognition: 2004
*Gallo Award for Outstanding Cancer Research presented by The Cancer Institute of NJ: 2000
*Manuscript Reviewer: Amer J Hlth-Syst Pharmacy (2004-2007); preclinical cancer journals (1990-2001)
*Editorial Board: Oncology Reports (1999-2000)
*Abstract Reviewer: Annual meetings, Amer Soc Gene Ther: 2001, 2002. Session moderator: 2001
*Grant Reviewer: Special Scientific Review Committee for the National Cancer Institute: 1994
